Effects of L-arginine on spontaneous contraction of the rat portal vein. 2003

Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, 1757 Kanazawa, Ishikari-Tobetsu, Hokkaido 061-0293, Japan. shimamu@hoku-iryo-u.ac.jp

The effects of L-arginine on spontaneous contraction of endothelium-denuded longitudinal preparations of the rat portal vein were studied. L-arginine increased the frequency of spontaneous contraction concentration-dependently between 10 microM and 1 mM. Changes in contraction amplitude and duration were not remarkable. D-arginine had a negligible effect on spontaneous contraction. N(omega)-nitro-L-arginine (1 mM) did not affect spontaneous contraction or the response to L-arginine. Addition of N(G)-monomethyl-L-arginine (1 mM), l-lysine (1 mM) or N-ethymaleimide (0.1 mM) increased the frequency of spontaneous contractions and inhibited the effect of L-arginine. Glibenclamide (10 microM) did not affect spontaneous contraction or the response to L-arginine. Spontaneous increase in concentration of intracellular Ca2+, estimated as the ratio of Fura-PE3 fluorescence occurred synchronously with spontaneous contraction. Spontaneous increase in concentration of intracellular Ca2+ occurred more frequently in the presence of L-arginine (1 mM). L-arginine (1 mM) also increased the number of action potential bursts/min in the longitudinal smooth muscle layer. L-arginine (1 mM) also depolarized cell membranes. This study indicates that L-arginine increases the frequency of spontaneous contraction of longitudinal muscle in the rat portal vein by membrane depolarization through mechanisms that do not involve nitric oxide or the inhibition of ATP-sensitive K+ channels.

UI MeSH Term Description Entries
D008297 Male Males
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
January 1984, Biological research in pregnancy and perinatology,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
June 2023, Amino acids,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
May 1998, General pharmacology,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
August 1972, Archives internationales de pharmacodynamie et de therapie,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
May 1989, Pflugers Archiv : European journal of physiology,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
March 1974, The American journal of physiology,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
December 2010, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
April 1993, Archives italiennes de biologie,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
March 1997, British journal of pharmacology,
Keiichi Shimamura, and Ming Zhou, and Miyuki Toba, and Shinichi Kimura, and Takashiro Higuchi, and Hideaki Kawaguchi, and Fumiko Sekiguchi, and Satoru Sunano
January 1979, Indian journal of physiology and pharmacology,
Copied contents to your clipboard!